Tevogen Bio Holdings (TVGN)

• Market cap: $124M
• 1 day: 4.65%
• 5 days: -0.73%
• 1 month: -19.98%
• 3 months: -36.48%
• 6 months: -38.99%
• Year to date: -40.72%
• 1 year: -75.16%
• 5 years: -93.68%
• 10 years: -93.68%
• Sector: Healthcare
• Industry: Biotechnology

About: Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Employees: 17